Medical News

RSS

Acid suppression drugs frequently prescribed for high-risk newborns, study shows

Since 2006, several published studies have associated the use of some acid suppression medications in hospitalized high-risk babies with infections, necrotizing enterocolitis and increased risk of death. Those medications - histamine-2 receptor antagonists, such as ranitidine (Zantac and others), and proton pump inhibitors, such as esomeprazole (Nexium and others) - were originally approved by the U.S. Food and Drug Administration for use in adults and older children.

27 Apr 2016

Allergen chip helps early detection of allergies

People can become allergically sensitized straight from birth. "Early screening is therefore important to detect allergies early so that steps can be taken to prevent serious forms of illness developing," say the MedUni Vienna allergy researchers, speaking on the occasion of World Immunology Day on 29 April and the current WHO World Immunization Week.

27 Apr 2016

New research suggests fasting not required before cholesterol, triglyceride measurement

New research from Denmark, Canada and the US involving more than 300,000 individuals suggests that patients do not need to check their cholesterol levels on an empty stomach. So far fasting has been required before cholesterol and triglyceride measurement in all countries except Denmark, where non-fasting blood sampling has been used since 2009.

27 Apr 2016

Working in night shifts may increase risk of coronary heart disease

Working at night is unhealthy for the heart and increases the risk of sustaining coronary heart disease, meaning a disease of the coronary arteries. This is the result of a current, and one of the largest American cooperation studies under the management of Eva Schernhammer of the epidemiology division of MedUni Wien, which was published in the top journal JAMA today. First author is Celine Vetter of Harvard University in Boston.

27 Apr 2016

PANDHUB project develops ways of reducing pandemic risk in transport hubs

Transport plays a major role in the spread of transmissible diseases. PANDHUB, a project coordinated by VTT Technical Research Centre of Finland Ltd, develops ways of reducing the risk of pandemics and managing other high-threat pathogen incidents in transport hubs.

27 Apr 2016

Researchers outline strategy to address vital measurement challenges in allergen analysis

A Manchester scientist has contributed to a review of allergen analysis that aims to improve the situation for those living with food allergies - preventing food fraud and protecting consumers.

27 Apr 2016

RADAR-CNS programme aims to improve lives of patients with brain disorders

A major new research program supported by the Innovative Medicines Initiative launches today, which will develop new ways of monitoring major depressive disorder, epilepsy, and multiple sclerosis using wearable devices and smartphone technology.

27 Apr 2016

Rapamycin drug could target neural damage linked to Leigh syndrome

Salk Institute scientists showed how an FDA-approved drug boosts the health of brain cells by limiting their energy use. Like removing unnecessary lighting from a financially strapped household to save on electricity bills, the drug--called rapamycin--prolongs the survival of diseased neurons by forcing them to reduce protein production to conserve cellular energy.

27 Apr 2016

New method measures LCO in person's standing posture to diagnose neuromuscular disorders

A new technique might be used to diagnose neuromuscular disorders such as multiple sclerosis or impairment from concussions by detecting and measuring subtle oscillations in a person's standing posture.

27 Apr 2016

TGen scientists trace likely origins, dispersal of fungus that causes Valley Fever

Using the latest in genomic analysis technologies, scientists at the Translational Genomics Research Institute have tracked the likely origins and dispersal of the fungus that causes Valley Fever, according to a study published today in the journal mBio, the premiere journal for reporting high impact microbiological research.

27 Apr 2016

UNC-Chapel Hill researchers identify functional brain circuit that controls alcohol binge drinking

Researchers at the University of North Carolina at Chapel Hill have identified a circuit between two brain regions that controls alcohol binge drinking, offering a more complete picture on what drives a behavior that costs the United States more than $170 billion annually and how it can be treated.

27 Apr 2016

Investigators explore possible causes for cancer recurrence after LRC

Although laparoscopic radical cystectomy (LRC) and robotic assisted radical cystectomy (RARC) continue to grow in popularity and are successful in the treatment of bladder cancer, they are still considered experimental approaches. Using data collected by the Section of Uro-Technology of the European Association of Urology (ESUT), a team of researchers found that about 5% of patients experienced unexpected relapses of cancer after LRC, even with favorable pathology.

27 Apr 2016

Mozambique women who use modern contraceptives more likely to undergo HIV testing

Women in sub-Saharan Africa who use modern contraceptives are more likely to be tested for HIV than those who do not, according to a study published April 25, 2016 in the open-access journal PLOS ONE by Katherine Center from the University of Arizona and colleagues.

27 Apr 2016

Study reveals new function for CACNA1C gene in psychiatric diseases

A new study shows the death of newborn brain cells may be linked to a genetic risk factor for five major psychiatric diseases, and at the same time shows a compound currently being developed for use in humans may have therapeutic value for these diseases by preventing the cells from dying.

27 Apr 2016

Review focuses on autologous cell therapy that can be applied to cardiac surgery

The combination of cell and gene therapy is rapidly raising clinical interest, although their combination has been under investigation for several decades. This is mainly due to the availability and feasibility of clinically relevant gene delivery options. This review focuses on cell therapies for heart failure and their use combined with cardiac surgery as well as with gene therapy.

27 Apr 2016

Lilly's ixekizumab (Taltz) granted EC marketing authorisation for treatment of plaque psoriasis

Eli Lilly and Company announced today that the European Commission has granted marketing authorisation for ixekizumab (Taltz) for the treatment of moderate-to-severe plaque psoriasis in adults in the European Union (EU) who are candidates for systemic therapy.

27 Apr 2016

WHO reminds Angola travellers to receive yellow fever vaccination

As efforts to bring an outbreak of yellow fever in Angola under control continue, the World Health Organization is reminding all travellers to the country that they are required to receive the yellow fever vaccination and to have a valid certificate of vaccination to prove that they are protected from the disease and to prevent its further spread.

27 Apr 2016

Protea signs license agreement with Yale to develop new technology for detecting malignant melanoma

Protea Biosciences Group, Inc. announced today that it had entered into an exclusive license agreement with Yale University for new technology to improve the differential diagnosis of malignant melanoma.

27 Apr 2016

Two London students make innovative medical devices to improve lives of people with Parkinson’s disease

Two London students, who have invented separate pieces of medical technology that could help revolutionise the lives of people with Parkinson’s disease, could soon see their innovative devices available to millions of sufferers after they were shortlisted for a prestigious award.

27 Apr 2016

University of Leicester-led researchers solve 3D structure of NuRD complex that plays role in cancer

A team of researchers led by the University of Leicester has shed new light on how the regulation machinery that controls gene expression works by characterising a complex known as the NuRD complex.

27 Apr 2016

Medical News

Acid suppression drugs frequently prescribed for high-risk newborns, study shows

Allergen chip helps early detection of allergies

New research suggests fasting not required before cholesterol, triglyceride measurement

Working in night shifts may increase risk of coronary heart disease

PANDHUB project develops ways of reducing pandemic risk in transport hubs

Researchers outline strategy to address vital measurement challenges in allergen analysis

RADAR-CNS programme aims to improve lives of patients with brain disorders

Rapamycin drug could target neural damage linked to Leigh syndrome

New method measures LCO in person's standing posture to diagnose neuromuscular disorders

TGen scientists trace likely origins, dispersal of fungus that causes Valley Fever

UNC-Chapel Hill researchers identify functional brain circuit that controls alcohol binge drinking

Investigators explore possible causes for cancer recurrence after LRC

Mozambique women who use modern contraceptives more likely to undergo HIV testing

Study reveals new function for CACNA1C gene in psychiatric diseases

Review focuses on autologous cell therapy that can be applied to cardiac surgery

Lilly's ixekizumab (Taltz) granted EC marketing authorisation for treatment of plaque psoriasis

WHO reminds Angola travellers to receive yellow fever vaccination

Protea signs license agreement with Yale to develop new technology for detecting malignant melanoma

Two London students make innovative medical devices to improve lives of people with Parkinson’s disease

University of Leicester-led researchers solve 3D structure of NuRD complex that plays role in cancer

Lab Matters host Harriet Gould on building a more connected lab community

The Critical Role of Sample Storage in Drug Discovery and Development

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

Latest News